Beijing Avistone Biotechnology Co., Ltd. Avistone is a commercial-stage innovative biopharmaceutical company, and is committed to delivering high-quality innovative drugs to oncology patients worldwide, enabling them to achieve a better quality of life.
Location: China, Beijing
Employees: 201-500
Investors 2
| Date | Name | Website |
| 11.02.2024 | Vivo Capit... | vivocapita... |
| 28.05.2024 | Bain Capit... | baincapita... |
Mentions in press and media 3
| Date | Title | Description |
| 04.01.2024 | Avistone Biotechnology Closes Series B Funding | Avistone Biotechnology, a Beijing, China-based biotechnology company focused on precision oncology therapeutics, closed a Series B financing of ~$140 million USD. The round was led by SDIC CS Capital and IDG Capital, with participation from... |
| 28.12.2023 | Deals in brief: OpenAI seeks fresh funding at valuation north of USD 100 billion, multiple China and India deals, and more | OpenAI is seeking funding at valuation north of USD 100 billion With the dust settling on the leadership tumult at OpenAI, during which Sam Altman was briefly displaced before being reinstated to the CEO position, the artificial intelligenc... |
| - | Avistone Pharmaceuticals | “Beijing Avistone Pharmaceuticals Biotechnology Co., Ltd.” |